{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:03:24Z","timestamp":1785420204298,"version":"3.56.0"},"reference-count":5,"publisher":"Rockefeller University Press","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011495","name":"Massachusetts Life Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01MD017816-01"],"award-info":[{"award-number":["1R01MD017816-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002567","name":"American Academy of Allergy Asthma & Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002567","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,5]]},"abstract":"<jats:p>A retrospective study indicates that nirmatrelvir\/ritonavir treatment during acute SARS-CoV-2 infection significantly reduces the risk of long COVID in patients with immunodeficiency. These findings may support early antiviral intervention to mitigate long-term sequelae in this vulnerable population, though prospective validation is required.<\/jats:p>","DOI":"10.70962\/jhi.20250107","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:21:36Z","timestamp":1761027696000},"update-policy":"https:\/\/doi.org\/10.70962\/jhi.crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Nirmatrelvir\/ritonavir use reduces risk for long COVID in patients with immunodeficiency"],"prefix":"10.70962","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3297-0250","authenticated-orcid":true,"given":"Karen M.","family":"Gilbert","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01zxdeg39","id-type":"ROR","asserted-by":"publisher"}],"name":"Harvard Pilgrim Health Care Institute 1 Department of Population Medicine, , Boston, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5849-1223","authenticated-orcid":true,"given":"Mostafa","family":"Aglan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03mbq3y29","id-type":"ROR","asserted-by":"publisher"}],"name":"Lahey Hospital and Medical Center 2 Department of Internal Medicine, , Burlington, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8483-7219","authenticated-orcid":true,"given":"Aditi","family":"Jogdand","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03mbq3y29","id-type":"ROR","asserted-by":"publisher"}],"name":"Clinical Immunodeficiency Program of Beth Israel Lahey Health, Lahey Hospital and Medical Center 3 Division of Allergy and Immunology, , Burlington, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9187-6734","authenticated-orcid":true,"given":"Neha V.","family":"Khairnar","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03mbq3y29","id-type":"ROR","asserted-by":"publisher"}],"name":"Comparative Effectiveness Research Institute (CERI), Lahey Hospital and Medical Center 4 , Boston, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2877-3465","authenticated-orcid":true,"given":"Henry","family":"Ssemaganda","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03mbq3y29","id-type":"ROR","asserted-by":"publisher"}],"name":"Comparative Effectiveness Research Institute (CERI), Lahey Hospital and Medical Center 4 , Boston, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1241-1013","authenticated-orcid":true,"given":"Mei-Sing","family":"Ong","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00dvg7y05","id-type":"ROR","asserted-by":"publisher"}],"name":"Computational Health Informatics Program, Boston Children\u2019s Hospital 5 , Boston, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-9848","authenticated-orcid":true,"given":"Jocelyn R.","family":"Farmer","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03mbq3y29","id-type":"ROR","asserted-by":"publisher"}],"name":"Clinical Immunodeficiency Program of Beth Israel Lahey Health, Lahey Hospital and Medical Center 3 Division of Allergy and Immunology, , Burlington, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"2026041713065458000_bib1","volume-title":"A Long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences [Internet]","author":"National Academies of Sciences, Engineering, and Medicine","year":"2024"},{"key":"2026041713065458000_bib2","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/jamainternmed.2023.0743","article-title":"Association of treatment with nirmatrelvir and the risk of post\u2013COVID-19 condition","volume":"183","author":"Xie","year":"2023","journal-title":"JAMA Intern. Med."},{"key":"2026041713065458000_bib3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/idr17030056","article-title":"Long COVID: A systematic review of preventive strategies","volume":"17","author":"Park","year":"2025","journal-title":"Infect. Dis. Rep."},{"key":"2026041713065458000_bib4","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/j.jaip.2023.05.029","article-title":"Association of inborn errors of immunity with severe COVID-19 and post-acute sequelae of COVID-19","volume":"11","author":"Farmer","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"2026041713065458000_bib5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41590-023-01724-6","article-title":"Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2","volume":"25","author":"Yin","year":"2024","journal-title":"Nat. Immunol."}],"container-title":["Journal of Human Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jhi\/article-pdf\/doi\/10.70962\/jhi.20250107\/1952801\/jhi_20250107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jhi\/article-pdf\/doi\/10.70962\/jhi.20250107\/1952801\/jhi_20250107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:06:57Z","timestamp":1776445617000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jhi\/article\/2\/1\/e20250107\/278440\/Nirmatrelvir-ritonavir-use-reduces-risk-for-long"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,5]]}},"URL":"https:\/\/doi.org\/10.70962\/jhi.20250107","relation":{},"ISSN":["3065-8993"],"issn-type":[{"value":"3065-8993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"article-number":"e20250107"}}